https://www.stockwatch.nl/wp-content/uploads/2024/06/NAP_HetBeurscafe_3200x1800px_PREMIUM_01.webp8441500Arend Jan Kamphttps://www.stockwatch.nl/wp-content/uploads/2024/06/StockWatch-logo-vignet-animated-darkmode.svgArend Jan Kamp2024-11-01 17:45:022024-11-26 10:47:2419. “Oktober was voor mij een horrormaand”
https://www.stockwatch.nl/wp-content/uploads/2024/06/NAP_HetBeurscafe_3200x1800px_PREMIUM_01.webp8441500Arend Jan Kamphttps://www.stockwatch.nl/wp-content/uploads/2024/06/StockWatch-logo-vignet-animated-darkmode.svgArend Jan Kamp2024-10-25 18:00:162024-11-01 14:30:4118. “Ik neem mijn verlies met Pharming”
https://www.stockwatch.nl/wp-content/uploads/2024/06/sto012-305132107.webp10001500Niels Koertshttps://www.stockwatch.nl/wp-content/uploads/2024/06/StockWatch-logo-vignet-animated-darkmode.svgNiels Koerts2024-10-24 09:15:502024-10-24 10:11:54Pharming moet aan de bak om aan eigen guidance te voldoen
https://www.stockwatch.nl/wp-content/uploads/2024/06/Unilever-003-producten.webp10121800Arend Jan Kamphttps://www.stockwatch.nl/wp-content/uploads/2024/06/StockWatch-logo-vignet-animated-darkmode.svgArend Jan Kamp2024-10-20 13:00:152024-10-21 18:57:09Vooruitblik Besi, Unilever, Heineken, Ebusco, Pharming en Tesla